MarketInOut Stock Screener Log In | Sign Up
 

Relay Therapeutics Inc

NASDAQ • Healthcare • Biotechnology • Quote as of 05/12/2026 16:00
Relay Therapeutics Inc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeNASDAQ
Market Capitalization2,444.64 mln
Float116 mln
Earnings Date08/06/2026

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-2.38
Borderline

1-Year Forecast

21.00
Transformational upside

Relative Strength

31 / 100
Underperforming

Debt / Equity

0.05
Debt-free

ROE

-42.56
Deeply negative

Business Description

Relay Therapeutics is a Cambridge, Massachusetts-based clinical-stage company focused on discovering new drugs to treat certain cancers and genetic diseases. Its main drug candidates target breast cancer, solid tumors, vascular malformations, and Fabry disease, with additional programs aimed at key cancer-driving proteins. The company works with partners including Pfizer, Elevar Therapeutics, and D. E. Shaw Research, using advanced computer modeling of protein behavior to guide its drug development efforts.

Key Fundamentals

EPS-1.56
ROE-42.56
RPS0.06
ROIC-562
ROA-38.75
EBITDA, mln-294
EV / EBITDA-6.04
EV / EBIT-5.98
Revenue, mln10.68
EV / Revenue166

Financial Strength

Altman Z-Score21.99
Piotroski F-Score 5 / 9
Beneish M-Score-2.38
1-Year Target Price21.00
Short Ratio8.43
Short % of Float16.83

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.54% 37 / 100   
1 Month -15.27% 9 / 100   
2 Months 49.13% 94 / 100   
6 Months 114% 97 / 100   
1 Year 331% 97 / 100   



Disclaimer - Privacy Policy - Terms Of Service - Cookie Use Policy - FAQ - Contact Us